elapegademase-lvlr (Revcovi)
elapegademase-lvlr is an FDA-licensed reference biologic from Chiesi USA, Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2018
Reference approved
Reference product
Revcovi elapegademase-lvlr
Chiesi USA, Inc.
- Approved
- Oct 05, 2018
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for elapegademase-lvlr, in chronological order.
Reference approval
Approval date of the reference elapegademase-lvlr product.
7 yr 9 mo ago
Orphan exclusivity ends
7-year orphan-drug exclusivity window.
8 mo ago
Frequently asked questions
Are there biosimilars approved for elapegademase-lvlr (Revcovi)?
No 351(k) biosimilars or interchangeable biosimilars referencing elapegademase-lvlr are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.